As per CNN Business Stock Price Forecast on Melinta (MLNT), The 4 analysts offering 12-month price forecasts have a median target of $30.00, with a high estimate of $70.00. 52-wk high was $42.70. U.S. FDA just accepted Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia. Float is only 8 million shares. MLNT can hit over $100. Cheers
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.